Components of the Interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness

Metabolism: Clinical and Experimental

Volumn 62, Issue 7, 2013, Pages 1008-1013

  Weiss, Thomas W ^a,b,c   Arnesen, Harald ^a,b   Seljeflot, Ingebjorg ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c WILHELMINEN HOSPITAL   (Austria)

Author keywords

Arterial stiffness; Inflammation; Interleukin 6; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; SOLUBLE GLYCOPROTEIN 130; SOLUBLE INTERLEUKIN 6 RECEPTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CYTOKINE RECEPTOR GP130; E-SELECTIN; EARLY DIAGNOSIS; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; METABOLIC SYNDROME X; RECEPTORS, INTERLEUKIN-6; RISK FACTORS; SIGNAL TRANSDUCTION; SOLUBILITY; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR STIFFNESS;

EID: 84879551082     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.01.019     Document Type: Article

References (31)

1. S.M. Grundy Metabolic syndrome pandemic Arterioscler Thromb Vasc Biol 28 4 2008 629 636
2. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 19 2001 2486 2497
3. L.W. Johnson, and R.S. Weinstock The metabolic syndrome: concepts and controversy Mayo Clin Proc 81 12 2006 1615 1620
4. A. Tenenbaum, and E.Z. Fisman "The metabolic syndrome. is dead": these reports are an exaggeration Cardiovasc Diabetol 10 1 2011 11
5. S.M. Haffner The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease Am J Cardiol 97 2A 2006 3A 11A
6. V.Z. Rocha, and P. Libby Obesity, inflammation, and atherosclerosis Nat Rev Cardiol 6 6 2009 399 409
7. R.R. Packard, and P. Libby Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction Clin Chem 54 1 2008 24 38
8. Paulus P, Jennewein C, Zacharowski K. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? Biomarkers 16 Suppl 1: S11-21.
9. C. Vlachopoulos, K. Aznaouridis, and C. Stefanadis Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis J Am Coll Cardiol 55 13 2010 1318 1327
10. H. Schuett, M. Luchtefeld, and C. Grothusen How much is too much? Interleukin-6 and its signalling in atherosclerosis Thromb Haemost 102 2 2009 215 222
11. J. Scheller, and S. Rose-John Interleukin-6 and its receptor: from bench to bedside Med Microbiol Immunol 195 4 2006 173 183
12. T. Taga, and T. Kishimoto Gp130 and the interleukin-6 family of cytokines Annu Rev Immunol 15 1997 797 819
13. M. Gwechenberger, R. Pacher, and R. Berger Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression J Heart Lung Transplant 24 12 2005 2190 2195
14. A. Deten, H.C. Volz, and W. Briest Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats Cardiovasc Res 55 2 2002 329 340
15. D. Marrone, G. Pertosa, and S. Simone Local activation of interleukin 6 signaling is associated with arteriovenous fistula stenosis in hemodialysis patients Am J Kidney Dis 49 5 2007 664 673
16. M. Luchtefeld, H. Schunkert, and M. Stoll Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man J Exp Med 204 8 2007 1935 1944
17. S.M. Grundy, J.I. Cleeman, and S.R. Daniels Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement Circulation 112 17 2005 2735 2752
18. G. Zuliani, M. Galvani, and M. Maggio Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance Atherosclerosis 213 1 2011 319 324
19. E.M. Hjerkinn, M. Abdelnoor, and L. Breivik Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia Eur J Cardiovasc Prev Rehabil 13 3 2006 325 333
20. I. Hjermann, K. Velve Byre, and I. Holme Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the oslo study group of a randomised trial in healthy men Lancet 2 8259 1981 1303 1310
21. I. Inta, D. Weber, and C. Grundt Correlation of soluble gp130 serum concentrations with arterial blood pressure J Hypertens 27 3 2009 527 534
22. M. Troseid, I. Seljeflot, and E.M. Hjerkinn Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia Diabetes Care 32 3 2009 486 492
23. T.W. Weiss, H. Arnesen, and M. Troseid Adipose tissue expression of interleukin-18 mrna is elevated in subjects with metabolic syndrome and independently associated with fasting glucose Wien Klin Wochenschr 2011
24. R. Piga, Y. Naito, and S. Kokura Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells Atherosclerosis 193 2 2007 328 334
25. T.W. Weiss, E.B. Furenes, and M. Troseid Prediction of cardiovascular events by matrix metalloproteinase (MMP)-9 in elderly men Thromb Haemost 103 3 2010 679 681
26. R. Huxley, S. Mendis, and E. Zheleznyakov Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk - a review of the literature Eur J Clin Nutr 64 1 2010 16 22
27. H.M. Eid, H. Arnesen, and E.M. Hjerkinn Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine Metabolism 53 12 2004 1574 1579
28. G.R. Hajer, T.W. van Haeften, and F.L. Visseren Adipose tissue dysfunction in obesity, diabetes, and vascular diseases Eur Heart J 29 24 2008 2959 2971
29. R. Mehra, A. Storfer-Isser, and H.L. Kirchner Soluble interleukin 6 receptor: a novel marker of moderate to severe sleep-related breathing disorder Arch Intern Med 166 16 2006 1725 1731
30. S.K. Kim, K.S. Kim, and Y.S. Lee Arterial stiffness and proinflammatory cytokines in fibromyalgia syndrome Clin Exp Rheumatol 28 6 Suppl 63 2010 S71 S77
31. Tuttolomondo A, Di Raimondo D, Pecoraro R, et al. Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke. Atherosclerosis 213(1): 311-8.